|
|
| (One intermediate revision by one other user not shown) |
| Line 1: |
Line 1: |
| ==Administration==
| | #REDIRECT[[Ofloxacin]] |
| *Type:
| |
| *Dosage Forms:
| |
| *Routes of Administration:
| |
| *Common Trade Names:
| |
| | |
| ==Adult Dosing==
| |
| ===[[Otitis Externa]]===
| |
| *5 drops in affected ear BID x 7 days<ref name="CPGENT2014">Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161 DOI: 10.1177/0194599813517659 [http://www.aepap.org/sites/default/files/otitis_externa_guia2014-rosenfeld-161-8_0.pdf PDF]</ref>
| |
| **Safe with perforations
| |
| | |
| ==Pediatric Dosing==
| |
| ===[[Otitis Externa]]===
| |
| *6mo-13 yo: 5 drops in affected ear BQD x 7 days
| |
| *>13 yo: *5 drops in affected ear BID x 7 days<ref name="CPGENT2014">Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161 DOI: 10.1177/0194599813517659 [http://www.aepap.org/sites/default/files/otitis_externa_guia2014-rosenfeld-161-8_0.pdf PDF]</ref>
| |
| | |
| ==Special Populations==
| |
| ===[[Drug pregnancy categories|Pregnancy Rating]]===
| |
| *
| |
| | |
| ===Lactation risk===
| |
| *
| |
| | |
| ===Renal Dosing===
| |
| *Adult:
| |
| *Pediatric:
| |
| | |
| ===Hepatic Dosing===
| |
| *Adult:
| |
| *Pediatric:
| |
| | |
| ==Contraindications==
| |
| *Allergy to class/drug
| |
| | |
| ==Adverse Reactions==
| |
| ===Serious===
| |
| | |
| | |
| ===Common===
| |
| | |
| | |
| ==Pharmacology==
| |
| *Half-life:
| |
| *Metabolism:
| |
| *Excretion:
| |
| | |
| ==Mechanism of Action==
| |
| | |
| | |
| ==Comments==
| |
| | |
| | |
| ==See Also==
| |
| | |
| | |
| ==References==
| |
| <references/>
| |
| | |
| [[Category:Pharmacology]]
| |
